Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Merriman Dwight ADirector | Open-market sale · 10b5-1 plan | SELL | $139K 340 sh | Jan 15, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $41K 300 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 3 | Prober Charles J.Director | Option exercise · 10b5-1 plan | M | — 7,930 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $41K 300 sh | Jan 15, 2026 traded Jan 14, 2026 |
| 2 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $59K 4,167 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 2 | Bentley Sheldon Richard10% Owner, Founder | Open-market sale · 10b5-1 plan | SELL | $21K 25.0K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 2 | Bentley Sheldon Richard10% Owner, Founder | Open-market sale · 10b5-1 plan | SELL | $22K 25.0K sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 12.1K sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Reed Cory JPres, Life Sol Cust Sup & S.M. | Option exercise · 10b5-1 plan | M | — 12.0K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 12.1K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 12.1K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $36K 3,542 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 4,167 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Morris DonnaExecutive Vice President | Grant or award · 10b5-1 plan | A | — 15.1K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 3,542 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Mahdessian AraDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 32.0K sh | Jan 15, 2026 traded Jan 15, 2026 |
| 0 | Mahdessian AraDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 32.0K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Sijbrandij SytseDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 54.3K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Sijbrandij SytseDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 54.3K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 51 | Feinberg PeterDirector | Open-market purchase | BUY | $87K 20.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 49 | Hildebrandt John DPresident and COO | Open-market sale | SELL | $1.02M 7,421 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 48 | DiGravio Karen AnnTrustee | Open-market purchase | BUY | $3,062 378 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 46 | Kovaleski PaulEVP-Chief Merch. Officer | Open-market sale | SELL | $582K 4,255 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 46 | Infante Beatriz VDirector | Open-market sale | SELL | $273K 1,995 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 44 | Brumana RodrigoChief Financial Officer | Open-market sale | SELL | $7,756 523 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 43 | Duffy Sean P.Director, Chief Executive Officer | Open-market sale | SELL | $1.45M 90.5K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 43 | Duffy Sean P.Director, Chief Executive Officer | Open-market sale | SELL | $2.15M 140.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 43 | Baller LanceDirector, 10% Owner | Open-market purchase | BUY | $14K 6,192 sh | Jan 14, 2026 traded Dec 18, 2025 |
| 40 | Billingsley ChesterDirector, Chief Executive Officer, 10% Owner | Open-market purchase | BUY | $204K 11 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 40 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Open-market sale | SELL | $1.37M 49.8K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 39 | Garg PushkalEVP Chief R&D | Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $81K 226 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $148K 405 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $133K 365 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Bricker JudeDirector, Chief Executive Officer | Open-market sale | SELL | $89K 5,062 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $102K 284 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $65K 181 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |